Skip to main content
Premium Trial:

Request an Annual Quote

If You Liked MIAME, You'll Love...

Frank Gibson blogs about the first of a two-day conference starting today on MIBBI (Minimum Information for Biological and Biomedical Investigations), a registry of scientific experiment reporting guidelines. The idea, he writes, is to "foster a foundry of best practice to further develop and encourage modular development and re-use of reporting guidelines." It sounds fun, especially considering that the schedule for day one is a series of five-minute talks (or, writes Gibson, "adjusting for an academic's interpretation of what 5 minutes means").

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.